Portfolio

AN2 Therapeutics

AN2 Therapeutics is developing novel therapies for neglected diseases.

Invested: 2019

Modality: Small Molecule

Website: an2therapeutics.com

Read Post

Themis is developing novel vaccines for high burden infectious diseases and oncology applications.

Invested: 2019

Modality: Vaccine

Website: themisbio.com

Read Post

InDevR is developing advanced characterization assays for biologics.

Invested: 2019

Modality: Process Innovation

Website: indevr.com

Read Post

X-Vax is developing a vaccine to beat herpes.

Invested: 2019

Modality: Vaccine

Website: x-vax.com

Read Post